XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (141) $ (2,582)
Adjustments to reconcile net loss to cash used in operating activities:    
Gain from sale of OSP (Note 3) (2,000) (4,552)
Depreciation and amortization 1,576 5,502
Long-lived asset impairment 170 36
Deferred income taxes (50) (49)
Inventory reserve 0 1,228
Non-cash interest 1,956 51
Stock-based compensation 1,201 1,668
Amortization of debt discount and financing costs 2,240 2,144
Other non-cash items affecting earnings 216 365
Changes in operating assets and liabilities, excluding the effects of asset sales [1] (12,298) (12,276)
Net cash used in operating activities (7,130) (8,465)
Cash flows from investing activities:    
Capital expenditures (372) (339)
Proceeds from sale of OSP, net of fees 2,000 4,500
Net cash provided by investing activities 1,628 4,161
Cash flows from financing activities:    
Borrowings on credit facility 4,000 11,357
Repayments of long-term debt (2,499) (9,491)
Debt refinancing fees (2,552) (4,383)
Taxes paid for shares withheld (16) (35)
Net cash used in financing activities (1,067) (2,552)
Effect of exchange rate changes on cash and cash equivalents (11) (103)
Decrease in cash, cash equivalents, and restricted cash (6,580) (6,959)
Cash, cash equivalents and restricted cash:    
Beginning of period 21,396 27,464
End of period $ 14,816 $ 20,505
[1] Changes in operating assets and liabilities exclude assets and liabilities sold.